UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release pertaining to the receipt of ANDA approval from the United States Food and Drug Administration (USFDA) for Unichem's Ranolazine Extended-Release Tablets, 500 mg, and 1000 mg. UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Financial Results for the quarter and nine months ended December 31, 2022, published in the newspapers on February 7, 2023. UNICHEM LABORATORIES LTD. - 506690 - Extension Of The Exercise Period For The Options Granted And Vested Under Unichem Employee Stock Option Scheme 2018.
Extension of the exercise period for the options granted and vested under Unichem Employee Stock Option Scheme 2018. UNICHEM LABORATORIES LTD. - 506690 - Board Meeting Outcome for Approval Of Unaudited Results (Standalone & Consolidated ) For The Third Quarter And Nine Months Ended 31.12.2022
Approval of Unaudited Results (standalone & consolidated ) for the third quarter and nine months ended 31.12.2022 UNICHEM LABORATORIES LTD. - 506690 - Clarification On The News.
clarification on the news item which appeared in the website 'www.economictimes.com' dated January 30, 2023 captioned 'Slovenian company Krka eyeing promoter stake in Unichem'. UNICHEM LABORATORIES LTD. - 506690 - Clarification sought from Unichem Laboratories Ltd
The Exchange has sought clarification from Unichem Laboratories Ltd on January 30, 2023, with reference to news appeared in economictimes.indiatimes.com dated January 30, 2023 quoting"Slovenian company Krka eyeing promoter stake in Unichem"The reply is awaited. UNICHEM LABORATORIES LTD. - 506690 - Board Meeting Intimation for Board Meeting For Inter Alia Approving Unaudited Results For The Quarter And Nine Months Ended December 31, 2022.
UNICHEM LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2023 ,inter alia, to consider and approve Board Meeting for approving unaudited results for the quarter and nine months ended December 31, 2022. UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Advertisement Published in Newspapers regarding a Notice for the transfer of Equity Shares and Unclaimed Dividends to the Investor Education and Protection Fund (IEPF) Account. UNICHEM LABORATORIES LTD. - 506690 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under regulation 74[5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2022. 